Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

<p>Abstract</p> <p>Background</p> <p>Although the impact of Aboriginal status on HIV incidence, HIV disease progression, and access to treatment has been investigated previously, little is known about the relationship between Aboriginal ethnicity and outcomes associated...

Full description

Bibliographic Details
Main Authors:	Daniel Mark, Moore David, Kerr Thomas, Bonner Simon, Palepu Anita, Kretz Patricia, Lima Viviane D, Montaner Julio SG, Hogg Robert S
Format:	Article
Language:	English
Published:	BMC 2006-05-01
Series:	AIDS Research and Therapy
Online Access:	http://www.aidsrestherapy.com/content/3/1/14

Similar Items

Rates of inappropriate antiretroviral prescription among injection drug users
by: Bonner Simon, et al.
Published: (2007-01-01)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
by: Palermo F, et al.
Published: (2010-05-01)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada.
by: Viviane D Lima, et al.
Published: (2010-06-01)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Functional changes of the vasculature in HIV/AIDS patients on Haart and Haart Naïve HIV participants
by: Awotedu, Kofoworola Olajire
Published: (2013)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
by: Tony Antoniou, et al.
Published: (2017-04-01)

Tolerability of antiretroviral therapy (HAART) in elderly age
by: Celesia B M
Published: (2010-05-01)

Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2012-01-01)

Asthma Mortality in Canada, 1946 to 1990
by: Robert S Hogg, et al.
Published: (1995-01-01)

Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development
by: Connie G. Chiu, et al.
Published: (2017-04-01)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
by: Arif Alibhai, et al.
Published: (2010-04-01)

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.
by: Robert S Hogg, et al.
Published: (2006-09-01)

Programmatic and Individual-level Factors Associated with CD4 Cell Count at HAART Initiation and Survival Among Treatment-naïve Patients Initiating HAART in sub-Saharan Africa.
by: Eduardo, Eduard
Published: (2014)

Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.
by: Julio S G Montaner, et al.
Published: (2014-01-01)

Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
by: Lealem Gedefaw, et al.
Published: (2013-01-01)

Factors that influence adherence to highly active antiretroviral therapy (HAART).
by: Naicker, Michaela Helene.
Published: (2013)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
by: Sinha Rajesh, et al.
Published: (2008-01-01)

Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
by: Hylemariam Mihiretie Mengist, et al.
Published: (2015-01-01)

Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
by: Hamilton Domingos, et al.

Behavioral Characteristics of Adult Patients on Highly Active Antiretroviral Therapy (HAART) in Uganda
by: Constance Shumba, et al.
Published: (2012-01-01)

Behavioral Characteristics of Adult Patients on Highly Active Antiretroviral Therapy (HAART) in Uganda
by: Constance Shumba
Published: (2012-01-01)

The impact of in-utero highly active antiretroviral therapy (HAART) exposure on infant outcomes
by: Van der Merwe, Karin Joan
Published: (2011)

Relationship between food insecurity and mortality among HIV-positive injection drug users receiving antiretroviral therapy in British Columbia, Canada.
by: Aranka Anema, et al.
Published: (2013-01-01)

Issues in HIV in the era of HAART
by: Moore, Antonia Louise
Published: (2004)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
by: Jielin Zhu, et al.
Published: (2019-08-01)

Maraviroc in Antiretroviral-Naïve HIV-1 Patients
by: Beniam Ghebremedhin
Published: (2012-01-01)

Maraviroc in Antiretroviral-Naïve HIV-1 Patients
by: Beniam Ghebremedhin
Published: (2012-01-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
by: N. Sunil Kumar, et al.
Published: (2015-07-01)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
by: Dereudre-Bosquet Nathalie, et al.
Published: (2009-09-01)

The impact of Highly Active Antiretroviral Therapy (HAART) on perceived health and labour supply in Khayelitsha
by: Coetzee, Celeste
Published: (2014)

Kepatuhan pesakit HIV positif terhadap rawatan Highly Active Antiretroviral Therapy (HAART)
by: Najwa Afiqa Roshaizad, et al.
Published: (2020)

Pharmacokinetic Considerations for Selection of HAART in Treatment-Naive HIV-Infected Individuals, 2008: More Than it Seems?
by: Andrew D. Luber PharmD
Published: (2008-03-01)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children.
by: Nikmah S Idris, et al.
Published: (2016-01-01)

High prevalence of HIV infection among homeless and street-involved Aboriginal youth in a Canadian setting
by: Li Kathy, et al.
Published: (2008-11-01)

Impacts of highly active antiretroviral therapy (HAART) on metabolic status of patients with AIDS; what happens from the initiation of AIDS to the initiation of treatment
by: alireza abdollahi, et al.
Published: (2014-08-01)

Impacts of highly active antiretroviral therapy (HAART) on metabolic status of patients with AIDS: What happens from the initiation of AIDS to the initiation of treatment?
by: Alireza Abdollahi, et al.
Published: (2014-01-01)

Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al.

Prevalence of depressive symptoms amongst highly active antiretroviral therapy (HAART) patients in AIDSRelief Uganda
by: Constance Shumba, et al.
Published: (2013-11-01)

Ocular problems in brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era
by: Marcia Lopes Rodrigues, et al.